Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 3 de 3
Filtrar
1.
Br J Pharmacol ; 171(3): 567-79, 2014 Feb.
Artigo em Inglês | MEDLINE | ID: mdl-23802760

RESUMO

Pulmonary arterial hypertension (PAH) is a complex disease characterized by elevated pulmonary arterial pressure, pulmonary vascular remodelling and occlusive pulmonary vascular lesions, leading to right heart failure. Evidence from recent epidemiological studies suggests the influence of gender on the development of PAH with an approximate female to male ratio of 4:1, depending on the underlying disease pathology. Overall, the therapeutic strategy for PAH remains suboptimal with poor survival rates observed in both genders. Endogenous sex hormones, in particular 17ß oestradiol and its metabolites, have been implicated in the development of the disease; however, the influence of sex hormones on the underlying pathobiology remains controversial. Further understanding of the influence of sex hormones on the normal and diseased pulmonary circulation will be critical to our understanding the pathology of PAH and future therapeutic strategies. In this review, we will discuss the influence of sex hormones on the development of PAH and address recent controversies.


Assuntos
Fármacos Cardiovasculares/uso terapêutico , Medicina Baseada em Evidências , Hipertensão Pulmonar/tratamento farmacológico , Pulmão/efeitos dos fármacos , Modelos Biológicos , Circulação Pulmonar/efeitos dos fármacos , Androgênios/metabolismo , Animais , Suscetibilidade a Doenças , Resistência a Medicamentos , Estrogênios/metabolismo , Hipertensão Pulmonar Primária Familiar , Feminino , Humanos , Hipertensão Pulmonar/epidemiologia , Hipertensão Pulmonar/metabolismo , Hipertensão Pulmonar/terapia , Incidência , Pulmão/irrigação sanguínea , Pulmão/metabolismo , Masculino , Receptores de Estrogênio/metabolismo , Caracteres Sexuais , Resistência Vascular/efeitos dos fármacos
2.
Br J Pharmacol ; 161(1): 176-92, 2010 Sep.
Artigo em Inglês | MEDLINE | ID: mdl-20718749

RESUMO

BACKGROUND AND PURPOSE: Anandamide and sphingosine-1-phosphate (S1P) both regulate vascular tone in a variety of vessels. This study aimed to examine the mechanisms involved in the regulation of coronary vascular tone by anandamide and S1P, and to determine whether any functional interaction occurs between these receptor systems. EXPERIMENTAL APPROACH: Mechanisms used by anandamide and S1P to regulate rat coronary artery (CA) reactivity were investigated using wire myography. Interactions between S1P and the cannabinoid (CB)(2) receptor were determined using human embryonic kidney 293 (HEK293) cells that stably over-express recombinant CB(2) receptor. KEY RESULTS: Anandamide and S1P induced relaxation of the rat CA. CB(2) receptor antagonists attenuated anandamide-induced relaxation, while S1P-mediated relaxation was dependent on the vascular endothelium and S1P(3). Anandamide treatment resulted in an increase in the phosphorylation of sphingosine kinase-1 within the CA. Conversely, anandamide-mediated relaxation was attenuated by inhibition of sphingosine kinase. Moreover, S1P(3), specifically within the vascular endothelium, was required for anandamide-mediated vasorelaxation. In addition to this, S1P-mediated relaxation was also reduced by CB(2) receptor antagonists and sphingosine kinase inhibition. Further evidence that S1P functionally interacts with the CB(2) receptor was also observed in HEK293 cells over-expressing the CB(2) receptor. CONCLUSIONS AND IMPLICATIONS: In the vascular endothelium of rat CA, anandamide induces relaxation via a mechanism requiring sphingosine kinase-1 and S1P/S1P(3). In addition, we report that S1P may exert some of its effects via a CB(2) receptor- and sphingosine kinase-dependent mechanism, where subsequently formed S1P may have privileged access to S1P(3) to induce vascular relaxation.


Assuntos
Ácidos Araquidônicos/farmacologia , Vasos Coronários/fisiologia , Lisofosfolipídeos/farmacologia , Alcamidas Poli-Insaturadas/farmacologia , Esfingosina/análogos & derivados , Animais , Ácidos Araquidônicos/administração & dosagem , Bloqueadores dos Canais de Cálcio/administração & dosagem , Bloqueadores dos Canais de Cálcio/farmacologia , Fármacos Cardiovasculares/administração & dosagem , Fármacos Cardiovasculares/farmacologia , Linhagem Celular , Dronabinol/análogos & derivados , Dronabinol/farmacologia , Endocanabinoides , Humanos , Indóis/farmacologia , Indometacina/administração & dosagem , Indometacina/farmacologia , Lisofosfolipídeos/administração & dosagem , Masculino , Alcamidas Poli-Insaturadas/administração & dosagem , Ratos , Ratos Sprague-Dawley , Receptor CB2 de Canabinoide/antagonistas & inibidores , Esfingosina/administração & dosagem , Esfingosina/farmacologia , Vasodilatação
3.
Br J Pharmacol ; 155(4): 606-16, 2008 Oct.
Artigo em Inglês | MEDLINE | ID: mdl-18695640

RESUMO

BACKGROUND AND PURPOSE: While the 5-HT and Rho-kinase (ROCK) pathways have been implicated in the development of pulmonary arterial hypertension (PAH), the nature of any interactions between them remain unclear. This study investigated a role for ROCK in 5-HT-regulated proliferative responses in lung fibroblasts in vivo and in vitro. EXPERIMENTAL APPROACH: PAH was examined in mice over-expressing human 5-HT transporters (SERT+), from which pulmonary artery fibroblasts (PFs) were isolated to assess ROCK expression. In vitro analysis of 5-HT signalling employed CCL39 hamster lung fibroblasts. KEY RESULTS: ROCK inhibition ablated increased pulmonary remodelling and hypertension observed in SERT+ mice, and ROCK1/2 protein levels were elevated in SERT+ PFs. ROCK inhibition also reduced 5-HT-stimulated proliferation by suppressing MEK-stimulated ERK phosphorylation. While optimal 5-HT-stimulated proliferation required 5-HT(1B) and 5-HT(2A) receptors and SERT, receptor sensitivity to Y27632 was restricted to the 5-HT(1B) receptor. Also, while hypoxia-induced pulmonary vascular remodelling and hypertension were sensitive to Y27632 in WT and SERT+ animals, the proportions sensitive to ROCK inhibition were increased by SERT over-expression. CONCLUSIONS AND IMPLICATIONS: SERT over-expression increased ROCK-dependent pulmonary remodelling in normoxia and hypoxia and SERT over-expression was associated with elevated ROCK1/2 levels. ROCK also potentiated 5-HT(1B) receptor-stimulated ERK activation and proliferation in vitro by facilitating MEK-ERK interaction.


Assuntos
Receptor 5-HT1B de Serotonina/metabolismo , Proteínas da Membrana Plasmática de Transporte de Serotonina/metabolismo , Amidas/farmacologia , Animais , Anti-Hipertensivos/farmacologia , Proliferação de Células , Cricetinae , Cricetulus , MAP Quinases Reguladas por Sinal Extracelular/metabolismo , Fibroblastos/metabolismo , Humanos , Hipertensão Pulmonar/fisiopatologia , Hipóxia/metabolismo , Camundongos , Camundongos Endogâmicos C57BL , Artéria Pulmonar/citologia , Artéria Pulmonar/metabolismo , Piridinas/farmacologia , Receptor 5-HT1B de Serotonina/efeitos dos fármacos , Receptor 5-HT2A de Serotonina/metabolismo , Transdução de Sinais/fisiologia , Quinases Associadas a rho/metabolismo
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA